Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Revision
Amendment no 1, cfr. document issued AMENDEMENT NO. 1 - RFP-DAN-2026-503942 - 16-Nov-2026
Tender Value
Refer Docs
Bid Security (EMD)
Refer Docs
Closing Date
18 Jan 2027, 16:59 (+02:00)18 Jan 2027, 8:29 pm IST
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
This tender is being launched to expand and strengthen the existing supply base for the supply of medicines for the management of cancer in children and adolescents. The tender includes newly introduced products as well as products for which limited or insufficient offers were received under previous tender processes, with the aim of ensuring a broader, more sustainable, and competitive supply of these essential medicines.
321403
RFP-DAN-2026-503942
Request for proposal
Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Indian Ocean Territory, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cabo Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Colombia, Comoros, Republic of the Congo, Cook Islands, Costa Rica, Côte d’Ivoire, Croatia, Cuba, Cyprus, Czechia, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Timor-Leste, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao, North Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn Islands, Poland, Portugal, Puerto Rico, Qatar, Réunion, Romania, Russia, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, Samoa, San Marino, São Tomé and Príncipe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Svalbard and Jan Mayen, Eswatini, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Türkiye, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, Tanzania, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, British Virgin Islands, United States Virgin Islands, Wallis and Futuna, Western Sahara, Yemen, Zambia, Zimbabwe, Antarctica, Palestine, Serbia, Montenegro, Kosovo, South Sudan
RFP
+02:00
21 Nov 2026
5 Nov 2026
ANNEX E - Commercial Logistics Information Template RFP-DAN-2026-503942 - THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS This sheet is not required to be submitted with the rest of the Commercial Documents. This sheet shall be returned upon request from UNICEF.
Item No. Short description Dosage Forms Indicative pack size and type (Other pack sizes/types will be considered) Offered Product by Supplier Production Capacity Per Month (in number of Packs, Bottles etc..) Production Capacity Per Month (in number of individual Items e.g. vials, tabs etc...) Manufacturing Site Name and Address ( where more than one manufactruing site was approved by UNICEF or is subject to GMP inspection please also mention here) Cold chain product Yes/No Transport conditions (numerical e.g. between +15°C to +25°C) Number of units in One Shipper Carton Length of Shipper carton (cm) Width of Shipper Carton (cm) Height of Shipper Carton (cm) LxWxH (cm) Concatenated from Cells L*M*N Weight of Shipper carton (kg) Number of Shipper cartons / Pallet Pallet Dimension Length (cm) Pallet Dimension Width (cm) Pallet Dimension Height (cm) Pallet dimensions (cm) Concatenated from Cells Q*R*S Pallet weight (kg)
RFP-DAN-2026-503942 THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS
Amendment No. 1 - Annex C Product list to be procured
Item No. Short description General description Route of Administration Technical specification (Different strengh may be considered) INN Indicative pack size and type (Different pack sizes/types will be considered) Anticipated Demand (based on 12 countries)
10 Calcium folinate 5mg tabs Calcium folinate 5mg tablets Oral Each tablet contains calcium folinate, which is equivalent to 5mg folinic acid (leucovorin) Calcium folinate Blister pack of 28 9000 tablet / year (assumes ongoing use of 15 mg tablet)
20 Calcium folinate 15mg tabs Calcium folinate 15mg tablets Oral Each tablet contains calcium folinate, which is equivalent to 15mg folinic acid (leucovorin) Calcium folinate Blister pack of 28 9000 - 20000 tablet / year (higher if no 5 mg tablet available)
30 Calcium folinate 3mg/ml inj 10ml Calcium folinate 3mg/ml solution for injection or infusion, 10ml vial or ampoule (for IV use) Parenteral Each ml contains calcium folinate equivalent to 3mg folinic acid Calcium folinate Pack of 1 vial 25000 - 35000 ampoule / year (one size).
40 Calcium folinate 7.5mg/ml inj 2ml Calcium folinate 7.5mg/ml solution for injection or infusion, 2ml ampoule or vial (for IV use) Parenteral Each ml contains calcium folinate equivalent to 7.5mg folinic acid Calcium folinate Pack of 1 vial 25000 - 35000 ampoule / year (one size).
60 Cyclophosphamide 200mg powder for inj Cyclophosphamide 200 mg powder for injection in vial (for IV use) Parenteral Each vial contains Cyclophosphamide 200mg powder for injection Cyclophosphamide Pack of 1 vial 15000 - 45000 vials / year (dependent upon mix of products)
70 Cyclophosphamide 500mg powder for inj Cyclophosphamide 500 mg powder for injection in vial (for IV use) Parenteral Each vial contains Cyclophosphamide 500mg powder for injection Cyclophosphamide Pack of 1 vial 15000 - 45000 vials / year (dependent upon mix of products)
50 Cyclophosphamide 1000mg powder for inj Cyclophosphamide 1000 mg powder for injection in vial (for IV use) Parenteral Each vial contains Cyclophosphamide 1000mg powder for injection Cyclophosphamide Pack of 1 vial 15000 - 45000 vials / year (dependent upon mix of products)
80 Dexamethasone 0.5mg tabs Dexamethasone 0.5mg tablets (as dexamethasone base) Oral Each tablet contains 0.5mg of dexamethasone Dexamethasone Blister pack of 10x10 150000 tablets / year
90 Dexamethasone 4mg tabs Dexamethasone 4mg tablets (as dexamethasone base) Oral Each tablet contains 4mg of dexamethasone Dexamethasone Blister pack of 10x10 or jar of 100 250000 tablets / year
100 Hydrocortisone 100mg 100 mg in vial (as sodium succinate) Preservative Free vial Parenteral Each vial contains Hydrocortisone 100mg (as sodium succinate) powder for injection (Product should be preservative free) Hydrocortisone Box of 10 vials 10400 vials / year
110 Methotrexate 1000mg/10ml concentrated inj Parenteral, IV: 1000 mg per 10 mL concentrated injection Parenteral Each ml contains 100 mg of methotrexate (as methotrexate sodium) Methotrexate Pack of 1 vial 35000 vials / year
120 Methotrexate 25mg/ml inj 2ml vl Methotrexate 25mg/ml solution for injection (for IV, IM and IT use) in 2ml vial Parenteral Each ml of solution contains 25mg of methotrexate (50mg/2ml). Should be suitable for intrathecal use Methotrexate Pack of 1 vial (2ml) 45000 vials / year
130 Methotrexate 10mg tabs Methotrexate 10mg tablets Oral Each tablet contains 10 mg methotrexate. Methotrexate Blister pack of 28 200000 tablets / year
140 Prednisolone 25mg/5ml oral sol Prednisolone 25mg/5ml oral solution Oral Each 1ml of solution contains 5mg of prednisolone (as prednisolone sodium phosphate). Bottle of 30ml preferred. It should come with a graduated dosing device. Other bottle volumes may be considered. Prednisolone 1 bottle 7500 bottles / year
150 Prednisolone 5mg soluble tabs Prednisolone 5mg soluble tablets Oral Each soluble tablet contains 5mg of prednisolone. Prednisolone Blister pack of 30 150000 tablets / year
160 Prednisolone 15mg tabs Prednisolone 15mg tablets Oral Each tablet contains 15mg of prednisolone. Prednisolone Blister pack of 28 200000-300000 tablets / year (dependent upon mix of products; assumes only 1 new prednisolone tablet size)
170 Prednisolone 20mg tabs Prednisolone 20mg tablets Oral Each tablet contains 20mg of prednisolone. Prednisolone Blister pack of 28 200000-300000 tablets / year (dependent upon mix of products; assumes only 1 new prednisolone tablet size)
180 Prednisolone 25mg tabs Prednisolone 25mg tablets Oral Each tablet contains 25mg of prednisolone. Prednisolone Blister pack of 28 200000-300000 tablets / year (dependent upon mix of products; assumes only 1 new prednisolone tablet size)
190 Prednisolone 30mg tabs Prednisolone 30mg tablets Oral Each tablet contains 30mg of prednisolone. Prednisolone Blister pack of 28 200000-300000 tablets / year (dependent upon mix of products; assumes only 1 new prednisolone tablet size)
200 Vinorelbine 10mg/ml in 1ml Vinorelbine 10mg/ml in 1ml vial Parenteral Each 1ml vial contains a total content of vinorelbine (as tartrate) of 10mg. Vinorelbine Pack of 1 vial 4000 vials / year (only 1 size needed)
210 Vinorelbine 10mg/ml in 5ml Vinorelbine 10mg/ml in 5ml vial Parenteral Each 5ml vial contains a total content of vinorelbine (as tartrate) of 50mg. Vinorelbine Pack of 1 vial 1400 vials / year (only 1 size needed)
220 Pegfilgrastim 4mg/0.4ml Pegfilgrastim 4mg/0.4ml Parenteral Each 0.4ml vial contains 4mg Pegfilgrastim Pegfilgrastim pack of 1 vial
AMENDMENT NO. 1 - ANNEX D - COMMERCIAL OFFER TEMPLATE
RFP-DAN-2026-503942 THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS
Contact person name:
UNICEF REQUIREMENT (Please Refer to Annex C - Product List for Detailed Specifications) SUPPLIER OFFER
Item No. Route of Administration Product Short description Indicative pack size and type (Other pack sizes/types will be considered) Item No. Description of Product Offered Strength Offered Dosage Form Offered Pack size Offered (total No. of Units in One Pack) Shelf-Life (in months only) MoQ (in number of packs, in figure only) MoQ (in number of individual tabs/vials etc.., in figure only) Cold chain product Yes/No Manufacturing Site Currency EUR/USD FCA Incoterms Logistics
FCA location (Name of Airport/Sea port) FCA Unit Price by Surface FCA Unit Price by Air Lead time (production time + transport time upto FCA named Airport/Seaport) in Number of Calendar Days Weight (KG) Per Pack Volume (M3) Per Pack Transport conditions (numerical e.g. between +15°C to +25°C) Number of Units in One Shipper Carton
10 Oral Calcium folinate 5mg tabs Blister pack of 28 10
20 Oral Calcium folinate 15mg tabs Blister pack of 28 20
30 Parenteral Calcium folinate 3mg/ml inj 10ml Pack of 1 vial 30
40 Parenteral Calcium folinate 7.5mg/ml inj 2ml Pack of 1 vial 40
50 Parenteral Cyclophosphamide 200mg powder for inj Pack of 1 vial 50
60 Parenteral Cyclophosphamide 500mg powder for inj Pack of 1 vial 60
70 Parenteral Cyclophosphamide 1000mg powder for inj Pack of 1 vial 70
80 Oral Dexamethasone 0.5mg tabs Blister pack of 10x10 80
90 Oral Dexamethasone 4mg tabs Blister pack of 10x10 or jar of 100 90
100 Parenteral Hydrocortisone 100mg Box of 10 vials 100
110 Parenteral Methotrexate 1000mg/10ml concentrated inj Pack of 1 vial 110
120 Parenteral Methotrexate 25mg/ml inj 2ml vl Pack of 1 vial (2ml) 120
130 Oral Methotrexate 10mg tabs Blister pack of 28 130
140 Oral Prednisolone 25mg/5ml oral sol 1 bottle 140
150 Oral Prednisolone 5mg soluble tabs Blister pack of 30 150
160 Oral Prednisolone 15mg tabs Blister pack of 28 160
170 Oral Prednisolone 20mg tabs Blister pack of 28 170
180 Oral Prednisolone 25mg tabs Blister pack of 28 180
190 Oral Prednisolone 30mg tabs Blister pack of 28 190
200 Parenteral Vinorelbine 10mg/ml in 1ml Pack of 1 vial 200
210 Parenteral Vinorelbine 10mg/ml in 5ml Pack of 1 vial 210
220 Parenteral Pegfilgrastim 4mg/0.4ml Pack of 1 vial 220
Commercial proposal is mandatory. Please submit this form in both Excel and signed and stamped Pdf Form.
Add additional row per each different strengh, pack size, surface transport mode to present a product offered
Unit price with two decimals only
For quoted unit prices please do not use commas, example:DO NOT USE 1,50 but USE 1.50.
Lead time in calendar days only
Do not merge neither cells, rows nor columns
IMPORTANT NOTES AMENDMENT NO. 1
This form shall be strcitly submitted only to [email protected] TECHNICAL BID FORM
Please do not send this form to any other e-mail address. Please do not upload this form to the Technical Folder RFP-DAN-2026-503942
Subject E-mail shall be : TECHNICAL BID FORM FOR RFP-DAN-2026-503942 THE SUPPLY OF MEDICINES FOR THE MANAGEMENT OF CANCER IN CHILDREN AND ADOLESCENTS
Guidance: 1) Save a local copy of this Excel sheet. 2) Fill out Table 2 below with the products your company has available. 3) If an alternative product is offered please enter a new column with full description of the product. 4) This document must be returned as an Excel sheet to [email protected] 5) This doucment must be sent seperately with no other forms.
Do NOT: Save this document as PDF, Word or scanned format. Do not insert documents, links or pictures in this Excel sheet.
Table 1: Example
General Description Product (INN) Dosage Form Strength per dosage unit Description of primary packaging (e.g. blister pack of 10 tablets, or 10 ml ampoule) Description of secondary packaging (i.e. Pack size offered; e.g. 10x10 tablets, 10 ampoules, 1 bottle, etc.) Language of label/Package insert Marketing Authorization (Agency, Licence number, country) WHO PQ (Y/N) WLA/SRA Approved (Y/N) Total Shelf Life (in Months) Storage Conditions Bidder Name Manufacturing Site (name & address) GMP inspection by: 1. WHO Prequalification Programme 2. SRA/WLA 3. PIC/S member country 4. UNICEF 5. Other Comments
Example 1 Calcium folinate 3 mg per mL in 10 mL ampoule Calcium folinate Solution for injection 3mg/ml 10ml ampoule Box of 10 ampoules Glass ampoules Packed in outer cardboard box English and Greek DKMA, Licence no 1234, Denmark N Y 36 months Do not store above 30 C. Company123 Company123, Street 1, City, State 2 (Denmarka) 4
Example 2 Procarbazine 50mg caps Procarbazine Capsule 50mg 5 x10 PVC/Alu Blister English and French DKMA, Licence no 1234, Denmark N Y 60 months Do not store above 30 C. Company123 Company123, Street 1, City, State 3 (Malaysia)
Table 2: Please fill out
General Description Product (INN) Dosage Form Strength per dosage unit Description of primary packaging (e.g. blister pack of 10 tablets, or 10 ml ampoule) Description of secondary packaging (i.e. Pack size offered; e.g. 10x10 tablets, 10 ampoules, 1 bottle, etc.) Language of label/Package insert Marketing Authorization (Agency, Licence number, country) WHO PQ (Y/N) WLA/SRA Approved (Y/N) Total Shelf Life (in Months) Storage Conditions Bidder Name Manufacturing Site (name & address) GMP inspection by: 1. WHO Prequalification Programme 2. SRA/WLA 3. PIC/S member country 4. UNICEF 5. Other Comments
RFP Item No. Product International Nonproprietary Name (INN) Formulations
10 Calcium folinate 5mg tabs Calcium folinate 5mg tablets
20 Calcium folinate 15mg tabs Calcium folinate 15mg tablets
30 Calcium folinate 3mg/ml inj 10ml Calcium folinate 3mg/ml solution for injection or infusion, 10ml vial or ampoule (for IV use)
40 Calcium folinate 7.5mg/ml inj 2ml Calcium folinate 7.5mg/ml solution for injection or infusion, 2ml ampoule or vial (for IV use)
50 Cyclophosphamide 200mg powder for inj Cyclophosphamide 200 mg powder for injection in vial (for IV use)
60 Cyclophosphamide 500mg powder for inj Cyclophosphamide 500 mg powder for injection in vial (for IV use)
70 Cyclophosphamide 1000mg powder for inj Cyclophosphamide 1000 mg powder for injection in vial (for IV use)
80 Dexamethasone 0.5mg tabs Dexamethasone 0.5mg tablets (as dexamethasone base)
90 Dexamethasone 4mg tabs Dexamethasone 4mg tablets (as dexamethasone base)
100 Hydrocortisone 100mg 100 mg in vial (as sodium succinate) Preservative Free vial
110 Methotrexate 1000mg/10ml concentrated inj Parenteral, IV: 1000 mg per 10 mL concentrated injection
120 Methotrexate 25mg/ml inj 2ml vl Methotrexate 25mg/ml solution for injection (for IV, IM and IT use) in 2ml vial
130 Methotrexate 10mg tabs Methotrexate 10mg tablets
140 Prednisolone 25mg/5ml oral sol Prednisolone 25mg/5ml oral solution
150 Prednisolone 5mg soluble tabs Prednisolone 5mg soluble tablets
160 Prednisolone 15mg tabs Prednisolone 15mg tablets
170 Prednisolone 20mg tabs Prednisolone 20mg tablets
180 Prednisolone 25mg tabs Prednisolone 25mg tablets
190 Prednisolone 30mg tabs Prednisolone 30mg tablets
200 Vinorelbine 10mg/ml in 1ml Vinorelbine 10mg/ml in 1ml vial
210 Vinorelbine 10mg/ml in 5ml Vinorelbine 10mg/ml in 5ml vial
220 Pegfilgrastim 4mg/0.4ml Each 0.4ml vial contains 4mg Pegfilgrastim
Name Of Company
Focal Point Name and Title
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
Annex 3- Instructions for uploading Technical Documents to Share Point library.pdf
Bidding document • 0.43 MB
Annex 2k - Declaration of Equivalence.docx
Bidding document • 0.08 MB
Annex 2j - Declaration of Similarity.pdf
Bidding document • 0.20 MB
Annex 2g - Tech commitment declaration form.docx
Bidding document • 0.05 MB
Annex 2f -UNICEF Abridged Finished Pharmaceutical Product Questionnaire.docx
Bidding document • 0.17 MB
Annex 2b - UNICEF Technical Questionnaire for pharmaceutical wholesalers.doc
Bidding document • 0.10 MB
Annex 2a -Tech Questionnaire for manufacturers.docx
Bidding document • 0.07 MB
Annex 2 - Instructions for Technical proposals and offers.pdf
Bidding document • 0.05 MB
Annex 1 UNICEF Technical Requirements_Pharmaceutical and Nutrition Edition 7.pdf
Bidding document • 0.87 MB
Annex I PAHO Purchase Order Template.pdf
Bidding document • 0.65 MB
Annex H - PAHO Notification Template.pdf
Bidding document • 0.13 MB
Annex G - UNICEF Purchase Order Template.pdf
Bidding document • 0.49 MB
Annex F - UNICEF Long Term Arrangement.pdf
Bidding document • 0.23 MB
Annex E - Commercial Logistics Information Template.xlsx
Bidding document • 0.03 MB
Annex B PAHO General Terms and Conditions.pdf
Bidding document • 0.24 MB
Annex A - UNICEF General Terms and Conditions of Contract.pdf
Bidding document • 0.16 MB
RFP-DAN-2026-503942.docx.pdf
Bidding document • 0.68 MB
Pre-bid webinar annoucement.docx
Bidding document • 0.07 MB
AMENDEMENT NO. 1 - RFP-DAN-2026-503942 - 16-Nov-2026.docx.pdf
Bidding document • 0.15 MB
Annex C - Product list - Amendment 1.xlsx
Bidding document • 0.02 MB
Annex D - Commercial Offer Template - Amendment 1.xlsx
Bidding document • 0.03 MB
Annex J - UNICEF Technical Bid Form - Amendment 1.xlsx
Bidding document • 0.03 MB
Annex 2c Interagency finished pharmaceutical product questionnaire (Automated form-version 21 Oct 2024).pdf
Bidding document • 0.78 MB
Annex 2d IAFPPQ Commitment and signature - Section 5.docx
Bidding document • 0.05 MB
Annex 2e UNICEF API Declaration for FPP manufacturer.docx
Bidding document • 0.05 MB
Annex 2i - Letter of authorization - Amendment 1.docx
Bidding document • 0.04 MB
Notice on UNGM.html
Notice page • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .